157 related articles for article (PubMed ID: 28096567)
1. Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection.
Choi B; Jo DH; Anower AK; Islam SM; Sohn S
Mediators Inflamm; 2016; 2016():4374375. PubMed ID: 28096567
[TBL] [Abstract][Full Text] [Related]
2. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.
Kassim SH; Rajasagi NK; Zhao X; Chervenak R; Jennings SR
J Virol; 2006 Apr; 80(8):3985-93. PubMed ID: 16571815
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
Bettahi I; Zhang X; Afifi RE; BenMohamed L
Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
[TBL] [Abstract][Full Text] [Related]
4. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections.
Deshpande SP; Kumaraguru U; Rouse BT
Cell Immunol; 2000 Jun; 202(2):79-87. PubMed ID: 10896767
[TBL] [Abstract][Full Text] [Related]
5. Dual TLR2/9 Recognition of Herpes Simplex Virus Infection Is Required for Recruitment and Activation of Monocytes and NK Cells and Restriction of Viral Dissemination to the Central Nervous System.
Uyangaa E; Choi JY; Patil AM; Hossain FMA; Park SO; Kim B; Kim K; Eo SK
Front Immunol; 2018; 9():905. PubMed ID: 29760708
[TBL] [Abstract][Full Text] [Related]
6. Herpes Simplex Virus 1 ICP22 Suppresses CD80 Expression by Murine Dendritic Cells.
Matundan H; Ghiasi H
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404803
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
[TBL] [Abstract][Full Text] [Related]
8. NKT cells determine titer and subtype profile of virus-specific IgG antibodies during herpes simplex virus Infection.
Raftery MJ; Wolter E; Fillatreau S; Meisel H; Kaufmann SH; Schönrich G
J Immunol; 2014 May; 192(9):4294-302. PubMed ID: 24683192
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
Mikloska Z; Cunningham AL
J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
[TBL] [Abstract][Full Text] [Related]
10. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells.
Ghasemi M; Erturk M; Buruk K; Sonmez M
Cytotherapy; 2013 Mar; 15(3):352-61. PubMed ID: 23579060
[TBL] [Abstract][Full Text] [Related]
11. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
12. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
[TBL] [Abstract][Full Text] [Related]
15. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
16. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
17. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
Mitchell BM; Stevens JG
J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
[TBL] [Abstract][Full Text] [Related]
18. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection.
Reading PC; Whitney PG; Barr DP; Smyth MJ; Brooks AG
Eur J Immunol; 2006 Apr; 36(4):897-905. PubMed ID: 16552715
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
20. The role of B lymphocytes in experimental herpes simplex viral retinitis.
Arrunategui-Correa V; Dutt J; Foster CS
Scand J Immunol; 1994 Sep; 40(3):299-307. PubMed ID: 8091129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
